The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia - Takeaways - MDSpire

The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia

  • By

  • Haoyu Wang

  • Fei Li

  • Haifan Wang

  • Zenan Tian

  • Hong Fan

  • Zhibin Shi

  • April 21, 2026

  • 0 min

Share

  • 1

    Resveratrol (RES) exhibits antioxidant, anti-inflammatory, and neuroprotective properties relevant to neurological disorders.

  • 2

    RES modulates biological pathways linked to neurodegeneration, including oxidative stress and inflammatory signaling.

  • 3

    Preclinical studies show RES improves cognitive performance and reduces neuroinflammatory markers in Alzheimer's and Parkinson's diseases.

  • 4

    Challenges for clinical application of RES include low bioavailability and limited clinical data on its efficacy.

  • 5

    Further well-designed clinical studies are necessary to establish the therapeutic relevance and safety of RES in human neurological disorders.

Original Source(s)

The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia

  • by Haoyu Wang, Fei Li, Haifan Wang, Zenan Tian, Hong Fan, Zhibin Shi

  • April 21, 2026

Related Content

Association of high-density lipoprotein cholesterol with the top 10 causes of death

Insights from Healthcare Providers on the Use of Social Robots in Dementia Care: Findings from Interviews and Focus Groups in France

Remote digital cognitive assessment for aging and dementia using the Oxford Cognitive Testing Portal OCTAL